Guan Q (2019) A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019:7247238

Article  PubMed  PubMed Central  Google Scholar 

Ramos GP, Papadakis KA (2019) Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc 94(1):155–165

Article  CAS  PubMed  Google Scholar 

Zhang M, Zhang S (2020) T Cells in Fibrosis and Fibrotic Diseases. Front Immunol 11:1142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Latella G et al (2015) Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J Gastroenterol 50(1):53–65

Article  CAS  PubMed  Google Scholar 

Powell DW et al (2011) Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol 73(1):213–237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vetuschi A et al (2018) PPAR-γ with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD. Eur Rev Med Pharmacol Sci 22(24):8839–8848

CAS  PubMed  Google Scholar 

Wang J et al (2021) Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 302(1):211–227

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cook SA, Schafer S (2020) Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation. Annu Rev Med 71(1):263–276

Article  CAS  PubMed  Google Scholar 

Zhang F et al (2019) Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20(7):928–942

Article  PubMed  PubMed Central  Google Scholar 

Wei K, Nguyen HN, Brenner MB (2021) Fibroblast pathology in inflammatory diseases. J Clin Invest 131(20):e149538

Huang B et al (2019) Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways. Cell 179(5):1160-1176.e24

Article  CAS  PubMed  Google Scholar 

Mack M (2018) Inflammation and fibrosis. Matrix Biol 68–69:106–121

Article  PubMed  Google Scholar 

Sanos SL, Diefenbach A (2010) Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol Biol 612:505–517

Article  CAS  PubMed  Google Scholar 

Zaiatz BV et al (2021) Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients. J Crohns Colitis 15(8):1316–1325

Article  Google Scholar 

Poggi A et al (2019) Human Gut-Associated Natural Killer Cells in Health and Disease. Front Immunol 10:961

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balsamo M et al (2009) Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 106(49):20847–20852

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greb-Markiewicz B et al (2019) The subcellular localization of bHLH transcription factor TCF4 is mediated by multiple nuclear localization and nuclear export signals. Sci Rep 9(1):15629

Article  PubMed  PubMed Central  Google Scholar 

Wirtz S et al (2017) Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc 12(7):1295–1309

Article  CAS  PubMed  Google Scholar 

Martin JC et al (2019) Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell 178(6):1493-1508.e20

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnhoorn MC et al (2020) Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 14(7):995–1009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowarski R, Jackson R, Flavell RA (2017) The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier. Cell 168(3):362–375

Article  CAS  PubMed  Google Scholar 

Kinchen J et al (2018) Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell 175(2):372-386.e17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yusung S et al (2017) NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn’s disease patients. Clin Immunol 175:82–90

Article  CAS  PubMed  Google Scholar 

Steel AW et al (2011) Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. Aliment Pharmacol Ther 33(1):115–126

Article  CAS  PubMed  Google Scholar 

Nusse R (2012) Wnt signaling. Cold Spring Harb Perspect Biol 4(5):a011163

Article  PubMed  PubMed Central  Google Scholar 

You J et al (2008) Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci 53(4):1013–1019

Article  CAS  PubMed  Google Scholar 

He S, Tang S (2020) WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother 132:110851

Article  CAS  PubMed  Google Scholar 

Liu J et al (2022) Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7(1):3

Article  PubMed  PubMed Central  Google Scholar 

Ohta K et al (2011) Tsukushi functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to transmembrane protein Frizzled4. Proc Natl Acad Sci U S A 108(36):14962–14967

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ortiz-Masià D et al (2020) WNT2b Activates Epithelial-mesenchymal Transition Through FZD4: Relevance in Penetrating Crohn´s Disease. J Crohns Colitis 14(2):230–239

Article  PubMed  Google Scholar 

Hodzic Z et al (2017) IL-33 and the intestine: The good, the bad, and the inflammatory. Cytokine 100:1–10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurimoto M et al (2021) IL-33 as a Critical Cytokine for Inflammation and Fibrosis in Inflammatory Bowel Diseases and Pancreatitis. Front Physiol 12:781012

Article  PubMed  PubMed Central